The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study
Matilde Tejlbo Frost,
Espen Jimenez-Solem,
Mikkel Zöllner Ankarfeldt,
Martin Erik Nyeland,
Anne Helms Andreasen,
Tonny Studsgaard Petersen
Affiliations
Matilde Tejlbo Frost
Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital
Espen Jimenez-Solem
Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital
Mikkel Zöllner Ankarfeldt
Copenhagen Phase IV Unit (Phase4CPH), Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg
Martin Erik Nyeland
Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital
Anne Helms Andreasen
Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg
Tonny Studsgaard Petersen
Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital